This article originally appeared on Undark. For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive neurodegenerative disease that is ...

New treatments for Alzheimer disease don’t reverse cognitive symptoms, but they do significantly slow progression. Evidence suggests that earlier treatment is most effective. In his first article, ...

A new study provides a well-needed glimmer of hope for treating Alzheimer’s disease. Focusing on a genetic form of early-onset dementia called dominantly inherited Alzheimer’s disease, scientists have ...

Amyloid fibrils have been targeted in a variety of neurodegenerative diseases. The amyloid cascade hypothesis, on which many modern Alzheimer's treatments are based, presumes that these fibrils are ...

Scientists find fat-derived particles could accelerate Alzheimer’s, connecting obesity to toxic brain changes. Study: Decoding adipose-brain crosstalk: Distinct lipid cargo in human adipose-derived ...

The search for an effective Alzheimer’s therapy has been a marathon rather than a sprint. At the end of 2022, it was reported that the anti-amyloid antibody lecanemab, which immunologically removes ...

Alzheimer’s disease is likely caused by stalled protein processing in the brain, according to a new study. The research, published today as a Reviewed Preprint in eLife, is described by editors as a ...